Related Experiment Video
Updated: Jul 31, 2025

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
A small epitope shared by p53 and an unrelated protein upregulated after adenovirus infection
1Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, and the Cellular and Molecular Medicine Graduate Program, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract:
Cancers commonly harbor point mutations in TP53 that cause overexpression of functionally inactive p53 proteins. These mutant forms of p53 are immunogenic, and therefore present tantalizing targets for new forms of immunotherapy. Understanding how the immune system recognizes p53 is an important prerequisite for the development of targeted therapeutic strategies designed to exploit this common neoantigen. Monoclonal antibodies have been extensively used to probe the structural conformation of the varied isoforms of p53 and their respective mutants, and are still indispensable tools for studying the complex biological functions of these proteins. In this report, we describe the mapping of a novel epitope on p53 that appears to be shared by heat shock proteins (HSPs), which are typically upregulated in response to a variety of viral infections.
Insights
Cancer-driving TP53 mutations create immunogenic p53 proteins, potential immunotherapy targets. Researchers mapped a novel p53 epitope shared with heat shock proteins (HSPs), crucial for understanding immune recognition.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Point mutations in tumor suppressor gene TP53 are frequent in cancers, leading to functionally inactive p53 proteins.
- These mutant p53 proteins are immunogenic, presenting opportunities for novel immunotherapies targeting cancer neoantigens.
- Understanding the immune system's recognition of p53 is critical for developing effective targeted therapies.
Approach:
- Utilized monoclonal antibodies to investigate the structural conformations of p53 isoforms and their mutants.
- Mapped a novel epitope on the p53 protein.
- Investigated the potential shared characteristics of this epitope with heat shock proteins (HSPs).
Key Points:
- Mutant p53 proteins, resulting from TP53 mutations in cancer, are recognized by the immune system.
- A novel epitope on p53 has been identified.
- This p53 epitope appears to be shared with heat shock proteins (HSPs).
Conclusions:
- The identified p53 epitope's shared nature with HSPs may influence immune recognition pathways.
- This finding provides a basis for developing immunotherapies that target p53 neoantigens.
- Further research into p53-HSP interactions could reveal new therapeutic strategies for cancer treatment.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Leaky Scanning

